Relates to requirements for electronic prescribing software under the medical assistance program; prohibits the use of advertising or messaging in such software, requires such software to include a means for prior authorization approval; prohibits use of certain information relating to a patient's benefits plan.
Sponsor: HANNON / Committee: HIGHER EDUCATION
Law Section: Education Law / Law: Amd S6810, Ed L
Sponsor: HANNON / Committee: HIGHER EDUCATION
Law Section: Education Law / Law: Amd S6810, Ed L
S6445-2011 Actions
- Feb 9, 2012: REFERRED TO HIGHER EDUCATION
S6445-2011 Memo
BILL NUMBER:S6445 REVISED 02/27/12 TITLE OF BILL: An act to amend the education law, in relation to electronic prescribing software PURPOSE: This legislation will prohibit certain practices aimed at influencing prescribers and pharmacies using electronic prescribing software. SUMMARY OF PROVISIONS: Section 1 adds a new section 6810(10) to the Education Law that: (a) Restricts information transmitted through electronic prescribing software to information consistent with the products label and/or infor- mation supported by scientific evidence that meets federal food and drug administration requirements for advertising pharmaceutical products, as well as facts from a review article or editorial comment in a major peer reviewed professional journal; (b) Prohibits advertisements, the use of instant messaging, and pop up ads to influence the prescriber; (c) Prohibits the use of a patient's formulary, co payment, or benefit plan to influence the prescriber; (d) Permits electronic prescribing software to request of prior authori- zation approval and receive authorization approval. Section 2 provides the effective date. This legislation will prohibit the use these tactics and allow physi- cians to focus on the patient's relevant health information rather than receive distracting marketing messages JUSTIFICATION: Technology has continued to evolve and provide medical professionals with effective tools to administer first rate health care. E-prescrib- ing software is an excellent example of how physicians are able to utilize this technology to improve patient care in a cost effective manner. Some entities that sell electronic prescribing software are attempting to influence physician prescribing via pop-up ads, instant messaging and other electronic means. Patient information including formularies, co-payment information and benefit information is also being used in marketing campaigns to influence health care professionals. LEGISLATIVE HISTORY: New bill. FISCAL IMPLICATIONS: None to the state. EFFECTIVE DATE: Immediate.
S6445-2011 Text
S T A T E O F N E W Y O R K
6445 I N SENATE February 9, 2012
Introduced by Sen. HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education
AN ACT to amend the education law, in relation to electronic prescribing software
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM BLY, DO ENACT AS FOLLOWS:
Section 1.
Section 6810 of the education law is amended by adding a new subdivision 10 to read as follows:
10. ALL ELECTRONIC PRESCRIBING SOFTWARE USED IN THIS STATE INCLUDING, WITHOUT LIMITATION, ELECTRONIC PRESCRIBING SOFTWARE FOR WHICH PRESCRI BERS AND PHARMACIES RECEIVE PAYMENTS PURSUANT TO SECTION THREE HUNDRED SIXTY-SEVEN-A OF THE SOCIAL SERVICES LAW SHALL:
(A) TRANSMIT TO A PRESCRIBER ONLY ELECTRONIC COMMUNICATIONS CONSISTENT WITH THE PRODUCT LABEL EXCEPT WHERE SUCH COMMUNICATION RELATES TO A REVIEW ARTICLE OR EDITORIAL COMMENT IN A MAJOR PEER REVIEWED PROFES SIONAL JOURNAL, SUPPORTED BY SCIENTIFIC EVIDENCE AND THAT MEETS THE FEDERAL FOOD AND DRUG ADMINISTRATION REQUIREMENTS FOR ADVERTISING PHAR MACEUTICAL PRODUCTS; (B) NOT USE ANY MEANS OR PERMIT ANY OTHER PERSON TO USE ANY MEANS, INCLUDING, BUT NOT LIMITED TO, ADVERTISING, INSTANT MESSAGING, AND POP UP ADS, TO INFLUENCE OR ATTEMPT TO INFLUENCE, THROUGH ECONOMIC INCEN TIVES OR OTHERWISE, THE PRESCRIBING DECISION OF A PRESCRIBING PRACTI TIONER AT THE POINT OF CARE OR ANY SUCH MEANS TRIGGERED OR IN SPECIFIC RESPONSE TO THE INPUT, SELECTION, OR ANY ACT OF A PRESCRIBING PRACTI TIONER OR HIS OR HER AGENT IN PRESCRIBING A CERTAIN PHARMACEUTICAL OR DIRECTING A PATIENT TO A CERTAIN PHARMACY; (C) NOT SHOW INFORMATION REGARDING A PAYOR'S FORMULARY, CO-PAYMENT OR BENEFIT PLAN IN ANY WAY THAT PRECLUDES OR MAKES MORE DIFFICULT THE ACT OF A PRESCRIBING PRACTITIONER OR PATIENT SELECTING ANY PARTICULAR PHAR MACY OR PHARMACEUTICAL; AND (D) MAKE AVAILABLE MEANS TO REQUEST A PRIOR AUTHORIZATION APPROVAL AND RECEIVE PRIOR AUTHORIZATION AND STEP THERAPY CRITERIA AND APPROVAL ELEC TRONICALLY ON THE DAY THE PRESCRIPTION IS ISSUED AS ESTABLISHED VIA A STANDARDIZED FORMAT TO BE CREATED BY THE BOARD OF PHARMACY.
S 2. This act shall take effect immediately. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD13447-01-1

*By contributing or voting you agree to the Terms of Participation and Privacy Policy and verify you are over 13.
Discuss!
blog comments powered by Disqus